Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
15.70    0.00 (0.00%)
Bid:
15.50
Ask:
15.70
Spread: 0.20 (1.29%)
Market Cap: £125.84m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Directorate Change

30 Jun 2008 07:00

RNS Number : 7977X
Manpower Software PLC
30 June 2008
 



For immediate release

30 June 2008

Manpower Software plc ("the Company") announces new appointment to the Board of Directors

Manpower Software plc, the leading supplier of workforce optimisation software applications, announces it has appointed Allen Arthur Albert Swann to serve as Business Development Director and a member of the Board of Directors with immediate effect.

Mr Swann is 57 years of age. He first became associated with the Company during February 2006 whilst acting as Interim Sales Director.  Since May 2007, he has focussed on building a substantial presence in the UK Healthcare Market.

Mr Swann is also Non Executive Chairman of the Board of CopperEye Ltd, a privately funded UK software company majoring in the telco marketplace, and a Non Executive Director of Chordiant Software Inc, a US based software company, which provides CRM software platforms to the world's largest financial institutions.  Prior to these appointments he served as International President for Chordiant Software Inc, International President of Prime Response Inc and was a founder member of Oracle UK, where he served as Sales Director both direct and non-direct for 12 years.

Terry Osborne, Manpower Software plc's Chairman, commented: "We are both fortunate and delighted that Allen, with his 25 years experience of the global software industry, will join us to provide strong business development leadership and execution skills at this critical stage in the Company's development.  His multi-national, multi-disciplined management abilities will be invaluable as the Company builds its sales and services capabilities to create profitable operations across multiple sectors and continents."

Allen Swann commented: "I am very pleased to be offered this opportunity to join the Board of Directors My association with the Company over the past 2.5 years has highlighted how important a role Manpower Software plc is playing in helping the UK Healthcare market more effectively utilise its staff, reduce costs, improve patient care and improve working lives.  There is an immense opportunity for the Company to continue to make a difference."

Details of Mr Swann's current and previous directorships in the past five years are set out below. 

Current directorships: Previous directorships:

UK:

CopperEye Ltd None

Overseas:

Chordiant Software Inc Solid Information Technology Inc

Mr Swann beneficially holds 1,119,000 Ordinary Shares, representing 2.5% of the Company's issued share capital.

In addition to the above, Mr Swann holds the following share options:

Scheme

Date of Grant

Number of options

Exercise price

Exercisable period

Unapproved Scheme

27.03.06

25,000

25.5p

27.03.09 - 26.03.16

Unapproved Scheme

9.10.06

225,000

18.5p

9.10.09 - 8.10.16

Total options held

250,000

There is no further information in connection with the appointment of Mr Allen Swann to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies

 

Enquiries:

Manpower Software plc

Ian Bowles CEO 020 7389 9500

Numis Securities Limited

Michael Meade 020 7260 1000James BlackBrent Nabbs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABRGDLCGDGGIR
Date   Source Headline
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results
4th Sep 20238:45 amRNSConference Attendance
30th Aug 20237:00 amRNSIssue of Equity - ESOP Options
22nd Aug 20237:00 amRNSIssue of Equity - Exercise of ESOP Options
17th Aug 20237:00 amRNSPartner Commits to Ewoyaa Development Funding
15th Aug 20237:00 amRNSMOU Signed for By-product Feldspar Study
10th Aug 20239:14 amRNSPCA Dealings
9th Aug 20239:30 amRNSDirector/PDMR Dealings
8th Aug 20237:00 amRNSResource and Exploration Drilling Results
7th Aug 20233:13 pmRNSStatement re Media Speculation
31st Jul 20237:00 amRNSQuarterly Activities and Cash Flow Report
19th Jul 20237:00 amRNSConference Attendance
13th Jul 20237:00 amRNSAppointment of Flotation Scoping Study Partner
30th Jun 20237:00 amRNSInvestor Presentation
29th Jun 20238:21 amRNSEwoyaa Definitive Feasibility Study
29th Jun 20237:17 amRNSEwoyaa Definitive Feasibility Study
23rd Jun 202311:00 amRNSBoard Appointments
20th Jun 20237:00 amRNSInitial Infill Drilling Results
16th Jun 20237:00 amRNSConference Attendance
13th Jun 20237:00 amRNSCorporate Update - Resignation of Director
1st Jun 20237:00 amRNSBoard Changes
26th May 20237:00 amRNSDTC Eligibility for OTCQX Electronic Trading
17th May 20237:00 amRNSConference Attendance
16th May 20237:00 amRNSAppointment of Chief Executive Officer
4th May 20237:00 amRNSConference Attendance
28th Apr 20237:00 amRNSQuarterly Activities and Cash Flow Report
26th Apr 20237:00 amRNSInternational Lithium Association Membership
19th Apr 20237:00 amRNSInfill Drilling and Passive Seismic Survey
6th Apr 20237:00 amRNSIssue of Equity – Exercise of ESOP Options
31st Mar 20237:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.